Annual Working Capital
$56.80 M
+$6000.00+0.01%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual working capital is $56.80 million, with the most recent change of +$6000.00 (+0.01%) on December 31, 2023.
- During the last 3 years, PBYI annual working capital has risen by +$24.92 million (+78.16%).
- PBYI annual working capital is now -71.46% below its all-time high of $199.01 million, reached on December 31, 2016.
Performance
PBYI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$46.42 M
+$13.00 M+38.88%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly working capital is $46.42 million, with the most recent change of +$13.00 million (+38.88%) on September 30, 2024.
- Over the past year, PBYI quarterly working capital has dropped by -$11.57 million (-19.95%).
- PBYI quarterly working capital is now -84.03% below its all-time high of $290.61 million, reached on March 31, 2015.
Performance
PBYI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PBYI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.0% | -19.9% |
| 3 y3 years | +78.2% | -19.2% |
| 5 y5 years | -58.2% | -19.2% |
PBYI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +86.6% | -27.0% | +52.5% |
| 5 y | 5-year | -24.7% | +86.6% | -38.5% | +124.7% |
| alltime | all time | -71.5% | >+9999.0% | -84.0% | >+9999.0% |
Puma Biotechnology Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $46.42 M(+38.9%) |
| Jun 2024 | - | $33.42 M(-25.5%) |
| Mar 2024 | - | $44.84 M(-21.1%) |
| Dec 2023 | $56.80 M(+0.0%) | $56.80 M(-2.1%) |
| Sep 2023 | - | $57.99 M(-0.5%) |
| Jun 2023 | - | $58.27 M(-8.3%) |
| Mar 2023 | - | $63.56 M(+11.9%) |
| Dec 2022 | $56.80 M(+86.6%) | $56.80 M(-8.9%) |
| Sep 2022 | - | $62.37 M(+8.6%) |
| Jun 2022 | - | $57.45 M(+34.3%) |
| Mar 2022 | - | $42.78 M(+40.6%) |
| Dec 2021 | $30.44 M(-4.5%) | $30.44 M(+47.3%) |
| Sep 2021 | - | $20.66 M(-30.8%) |
| Jun 2021 | - | $29.85 M(+27.8%) |
| Mar 2021 | - | $23.36 M(-26.7%) |
| Dec 2020 | $31.88 M(-57.7%) | $31.88 M(-23.4%) |
| Sep 2020 | - | $41.61 M(-35.7%) |
| Jun 2020 | - | $64.70 M(-5.2%) |
| Mar 2020 | - | $68.21 M(-9.6%) |
| Dec 2019 | $75.46 M(-44.5%) | $75.46 M(+20.2%) |
| Sep 2019 | - | $62.75 M(-4.8%) |
| Jun 2019 | - | $65.95 M(-57.4%) |
| Mar 2019 | - | $154.76 M(+13.9%) |
| Dec 2018 | $135.89 M(+182.8%) | $135.89 M(+16.6%) |
| Sep 2018 | - | $116.53 M(+9.4%) |
| Jun 2018 | - | $106.53 M(+100.7%) |
| Mar 2018 | - | $53.07 M(+10.4%) |
| Dec 2017 | $48.05 M(-75.9%) | $48.05 M(+115.1%) |
| Sep 2017 | - | $22.34 M(-80.3%) |
| Jun 2017 | - | $113.56 M(-29.4%) |
| Mar 2017 | - | $160.90 M(-19.1%) |
| Dec 2016 | $199.01 M | $199.01 M(+149.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $79.80 M(-30.5%) |
| Jun 2016 | - | $114.78 M(-23.7%) |
| Mar 2016 | - | $150.45 M(-21.3%) |
| Dec 2015 | $191.11 M(+82.1%) | $191.11 M(-16.7%) |
| Sep 2015 | - | $229.33 M(-12.4%) |
| Jun 2015 | - | $261.69 M(-10.0%) |
| Mar 2015 | - | $290.61 M(+176.9%) |
| Dec 2014 | $104.94 M(+36.1%) | $104.94 M(-19.7%) |
| Sep 2014 | - | $130.74 M(-16.0%) |
| Jun 2014 | - | $155.67 M(-18.7%) |
| Mar 2014 | - | $191.42 M(+148.2%) |
| Dec 2013 | $77.13 M(-39.4%) | $77.13 M(-15.6%) |
| Sep 2013 | - | $91.35 M(-11.8%) |
| Jun 2013 | - | $103.61 M(-11.1%) |
| Mar 2013 | - | $116.57 M(-8.4%) |
| Dec 2012 | $127.27 M(+139.8%) | $127.27 M(+1606.8%) |
| Sep 2012 | - | $7.46 M(-71.6%) |
| Jun 2012 | - | $26.29 M(-36.2%) |
| Mar 2012 | - | $41.23 M(-22.3%) |
| Dec 2011 | $53.08 M(>+9900.0%) | $53.08 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | -$1600.00(-27.3%) |
| Mar 2011 | - | -$2200.00(-540.0%) |
| Dec 2010 | $500.00(+400.0%) | $500.00(-76.2%) |
| Sep 2010 | - | $2100.00(+16.7%) |
| Jun 2010 | - | $1800.00(>+9900.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $100.00(-104.8%) | $100.00(0.0%) |
| Sep 2009 | - | $100.00(0.0%) |
| Jun 2009 | - | $100.00(-125.0%) |
| Mar 2009 | - | -$400.00(-81.0%) |
| Dec 2008 | -$2100.00 | -$2100.00 |
FAQ
- What is Puma Biotechnology annual working capital?
- What is the all time high annual working capital for Puma Biotechnology?
- What is Puma Biotechnology annual working capital year-on-year change?
- What is Puma Biotechnology quarterly working capital?
- What is the all time high quarterly working capital for Puma Biotechnology?
- What is Puma Biotechnology quarterly working capital year-on-year change?
What is Puma Biotechnology annual working capital?
The current annual working capital of PBYI is $56.80 M
What is the all time high annual working capital for Puma Biotechnology?
Puma Biotechnology all-time high annual working capital is $199.01 M
What is Puma Biotechnology annual working capital year-on-year change?
Over the past year, PBYI annual working capital has changed by +$6000.00 (+0.01%)
What is Puma Biotechnology quarterly working capital?
The current quarterly working capital of PBYI is $46.42 M
What is the all time high quarterly working capital for Puma Biotechnology?
Puma Biotechnology all-time high quarterly working capital is $290.61 M
What is Puma Biotechnology quarterly working capital year-on-year change?
Over the past year, PBYI quarterly working capital has changed by -$11.57 M (-19.95%)